The challenge of emerging SARS-CoV-2 mutants to vaccine development

J Genet Genomics. 2021 Feb 20;48(2):102-106. doi: 10.1016/j.jgg.2021.03.001. Epub 2021 Apr 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Binding Sites / genetics
  • Binding Sites / immunology
  • COVID-19 / epidemiology
  • COVID-19 / immunology*
  • COVID-19 / virology
  • COVID-19 Vaccines / genetics
  • COVID-19 Vaccines / immunology*
  • COVID-19 Vaccines / therapeutic use
  • Humans
  • Immune Evasion / genetics
  • Immune Evasion / immunology
  • Mutation
  • Pandemics / prevention & control
  • Protein Binding / immunology
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / physiology
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / immunology*
  • Spike Glycoprotein, Coronavirus / metabolism

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2